Literature DB >> 29096291

Discordant reporting of nonmedical amphetamine use among Adderall-using high school seniors in the US.

Joseph J Palamar1, Austin Le2.   

Abstract

BACKGROUND: Amphetamine is the most prevalent prescription stimulant in the United States, both medically and nonmedically. Reliable data on nonmedical use is needed to continue to inform prevention. To determine whether adolescents accurately self-report nonmedical amphetamine use, we compared self-reports of nonmedical amphetamine use and nonmedical Adderall use in a national sample.
METHODS: We examined self-reported nonmedical Adderall and amphetamine use in a nationally representative sample of 24,740 high school seniors in the Monitoring the Future study (2010-2015). We examined prevalence and correlates of discordant responses among past-year Adderall users, defined as reporting past-year nonmedical Adderall use, but not reporting past-year nonmedical amphetamine use.
RESULTS: While 6.9% reported nonmedical Adderall use and 7.9% reported nonmedical amphetamine use, over a quarter (28.7%) of Adderall users reported no amphetamine use. Those at highest risk for Adderall use tended to be at lower odds of providing a discordant response. Older students (aged ≥18), black students, and those with parents of lower educational attainment were more likely to report no amphetamine use, despite reporting Adderall use. Lifetime use of various drugs was associated with decreased odds of providing a discordant response; however, only nonmedical opioid use was associated with significant decreased odds in multivariable models. Disapproval towards amphetamine use increased odds of providing a discordant response, while higher exposure to users decreased odds of providing a discordant response.
CONCLUSION: Prevalence of nonmedical amphetamine use may be underreported on some surveys, particularly among specific subpopulations. Future surveys must ensure accurate and consistent responses.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adderall; Adolescents; Amphetamine; Reliability of self-report

Mesh:

Substances:

Year:  2017        PMID: 29096291      PMCID: PMC5689455          DOI: 10.1016/j.drugalcdep.2017.09.033

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  13 in total

1.  Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.

Authors:  Sean Esteban McCabe; John R Knight; Christian J Teter; Henry Wechsler
Journal:  Addiction       Date:  2005-01       Impact factor: 6.526

2.  Nonmedical Use and Diversion of ADHD Stimulants Among U.S. Adults Ages 18-49: A National Internet Survey.

Authors:  Theresa A Cassidy; Sajan Varughese; Leo Russo; Simon H Budman; Thomas A Eaton; Stephen F Butler
Journal:  J Atten Disord       Date:  2012-12-26       Impact factor: 3.256

3.  Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.

Authors:  Joseph J Palamar; Alberto Salomone; Enrico Gerace; Daniele Di Corcia; Marco Vincenti; Charles M Cleland
Journal:  Int J Drug Policy       Date:  2017-08-12

4.  Assessing self-reported use of new psychoactive substances: The impact of gate questions.

Authors:  Joseph J Palamar; Patricia Acosta; Fermín Fernández Calderón; Scott Sherman; Charles M Cleland
Journal:  Am J Drug Alcohol Abuse       Date:  2017-05-09       Impact factor: 3.829

Review 5.  Adderall® (amphetamine-dextroamphetamine) toxicity.

Authors:  Kevin T Fitzgerald; Alvin C Bronstein
Journal:  Top Companion Anim Med       Date:  2013-02

Review 6.  Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses.

Authors:  Nicolas Rasmussen
Journal:  Int Rev Neurobiol       Date:  2015-03-17       Impact factor: 3.230

7.  Prescriptions, nonmedical use, and emergency department visits involving prescription stimulants.

Authors:  Lian-Yu Chen; Rosa M Crum; Eric C Strain; G Caleb Alexander; Christopher Kaufmann; Ramin Mojtabai
Journal:  J Clin Psychiatry       Date:  2016-03       Impact factor: 4.384

Review 8.  The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.

Authors:  Robert C Spencer; David M Devilbiss; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2014-09-28       Impact factor: 13.382

9.  Crystals and tablets in the Spanish ecstasy market 2000-2014: Are they the same or different in terms of purity and adulteration?

Authors:  Claudio Vidal Giné; Mireia Ventura Vilamala; Iván Fornís Espinosa; Cristina Gil Lladanosa; Nú Calzada Álvarez; Ariadna Fitó Fruitós; Joan Rodríguez Rodríguez; Antonia Domíngo Salvany; Rafael de la Torre Fornell
Journal:  Forensic Sci Int       Date:  2016-04-20       Impact factor: 2.395

10.  What are we missing? The costs versus benefits of skip rule designs.

Authors:  Sonja A Swanson; Tiffany A Brown; Ross D Crosby; Pamela K Keel
Journal:  Int J Methods Psychiatr Res       Date:  2013-09-13       Impact factor: 4.035

View more
  7 in total

1.  What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.

Authors:  Natalie S Levy; Joseph J Palamar; Stephen J Mooney; Charles M Cleland; Katherine M Keyes
Journal:  Ann Epidemiol       Date:  2022-01-03       Impact factor: 6.996

2.  Self-Correction of Unreported Marijuana Use by Participants Taking a Street Intercept Survey.

Authors:  Joseph J Palamar; Austin Le
Journal:  Am J Drug Alcohol Abuse       Date:  2020-05-07       Impact factor: 3.829

3.  Underreporting of drug use on a survey of electronic dance music party attendees.

Authors:  Joseph J Palamar; Austin Le
Journal:  Addict Res Theory       Date:  2019-08-20

4.  Underreporting of past-year cannabis use on a national survey by people who smoke blunts.

Authors:  Austin Le; Benjamin H Han; Joseph J Palamar
Journal:  Subst Abus       Date:  2021-07-02       Impact factor: 3.716

5.  NarxCare Scores Greater Than 300 Are Associated with Adverse Outcomes After Primary THA.

Authors:  Ahmed K Emara; Daniel Grits; Alison K Klika; Robert M Molloy; Viktor E Krebs; Wael K Barsoum; Carlos Higuera-Rueda; Nicolas S Piuzzi
Journal:  Clin Orthop Relat Res       Date:  2021-09-01       Impact factor: 4.755

6.  Discordant report of vaping of cannabis among high school seniors in the United States.

Authors:  Joseph J Palamar; Austin Le
Journal:  Am J Drug Alcohol Abuse       Date:  2021-07-15       Impact factor: 3.912

7.  Neuroenhancement: State of the Art and Future Perspectives.

Authors:  Donatella Marazziti; Maria Teresa Avella; Tea Ivaldi; Stefania Palermo; Lucia Massa; Alessandra Della Vecchia; Lucia Basile; Federico Mucci
Journal:  Clin Neuropsychiatry       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.